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MouseProlonged maintenance of trophoblast stem (TS) cells requires ﬁbroblast growth factor (FGF) 4 and
embryonic ﬁbroblast feeder cells or feeder cell-conditioned medium. Previous studies have shown that TGF-
β and Activin are sufﬁcient to replace embryonic ﬁbroblast-conditioned medium. Nodal, a member of the
TGF-β superfamily, is also known to be important in vivo for the maintenance of TS cells in the developing
placenta. Our current studies indicate that TS cells do not express the Nodal co-receptor, Cripto, and do not
respond directly to active Nodal in culture. Conversely, Activin subunits and their receptors are expressed in
the placenta and TS cell cultures, with Activin predominantly expressed by trophoblast giant cells (TGCs).
Differentiation of TS cells in the presence of TGC-conditioned medium or exogenous Activin results in a
reduction in the expression of TGC markers. In line with TGC-produced Activin representing the active
component in TGC-conditioned medium, this differentiation-inhibiting effect can be reversed by the addition
of follistatin. Additional experiments in which TS cells were differentiated in the presence or absence of
exogenous Activin or TGF-β show that Activin but not TGF-β results in the maintenance of expression of TS
cell markers, prolongs the expression of syncytiotrophoblast markers, and signiﬁcantly delays the expression
of spongiotrophoblast and TGC markers. These results suggest that Activin rather than TGF-β (or Nodal) acts
directly on TS cells inﬂuencing both TS cell maintenance and cell fate, depending on whether the cells are
also exposed to FGF4.
© 2009 Elsevier Inc. All rights reserved.Introduction
The placenta is one of the ﬁrst organs to form during development
and is essential for a healthy pregnancy. At the time of implantation,
trophoblast cells of the mural trophectoderm in the blastocyst make
contact with the uterine epithelium and undergo terminal differen-
tiation. The resulting trophoblast giant cells (TGCs) are post-mitotic,
migrate into the uterine tissue, and line the developing implantation
site. The bulk of the developing placenta is formed from a
subpopulation of trophoblast cells that overlie the inner cell mass,
the polar trophectoderm (Gardner and Johnson, 1973; Gardner et al.,
1973; Simmons and Cross, 2005; Tanaka et al., 1998; Uy et al., 2002).
Following implantation, these trophoblast stem cells proliferate to
give rise to the extraembryonic ectoderm (also called chorionic
ectoderm) and ectoplacental cone (EPC). As development proceeds,
all of the different trophoblast subtypes required to form the mature
placenta, including TGCs, glycogen trophoblast cells, spongiotropho-
blasts, and syncytiotrophoblasts, are derived from these tissuesll rights reserved.(Gardner and Johnson, 1973; Gardner et al., 1973; Simmons et al.,
2007). However, in order for trophoblast proliferation and differen-
tiation to occur properly, a speciﬁc microenvironment must exist to
support the maintenance of the trophoblast stem cell population
(Guzman-Ayala et al., 2004). Fibroblast growth factor 4 (FGF4) is a
component of this microenvironment. FGF4 not only is required for
the proliferation of the inner cell mass and development of the
embryonic ectoderm following implantation (Feldman et al., 1995)
but also is essential for the derivation and maintenance of TS cells
in vitro (Goldin and Papaioannou, 2003; Gotoh et al., 2005; Tanaka
et al., 1998).
In addition to FGF4, members of the TGF-β superfamily of growth
factors have been shown to regulate TS cell maintenance and
differentiation (Erlebacher et al., 2004; Goumans and Mummery,
2000; Jones et al., 2006). The TGF-β superfamily of growth factors
includes TGF-βs, growth differentiation factors (GDFs), bone mor-
phogenetic proteins (BMPs), Nodal, Activins, and Inhibins. These
proteins regulate many developmental and physiological processes
and, in general, signal through transmembrane serine/threonine
kinase receptors and downstream Smad proteins to regulate cellular
functions (Chang et al., 2002). Signaling by these molecules can be
broadly divided into two distinct pathways, the GDF/BMP pathway,
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the TGF-β/Activin/Nodal pathway (Chang et al., 2002; de Caestecker,
2004). TGF-β initiates cellular responses by binding its heterotetra-
meric transmembrane receptor complex composed of Tgfbr1 (type I)
and Tgfbr2 (type II) receptors, whereas Activin and Nodal bind the
Activin receptors Acvr1b and Acvr2b (or Acvr2a) (de Caestecker,
2004; Derynck and Zhang, 2003). An additional level of complexity
and control exists with other proteins acting as ligand traps such as
Follistatin which binds Activin, and with co-receptors such as Cripto
which interacts speciﬁcally with Nodal (but not Activin) and the
Activin receptors (Shi and Massague, 2003). Downstream of the
receptor complexes, all three ligands transduce their signals through
phosphorylation of Smad2/Smad3, which complexes with Smad4 and
is translocated to the nucleus to regulate gene transcription (Shi and
Massague, 2003).
TGF-β and Activin have each been shown to be sufﬁcient,
together with FGF4, to support the proliferation and pluripotency
of undifferentiated TS cells in culture (Erlebacher et al., 2004).Fig. 1.Nodal cannot maintain the proliferation of undifferentiated TS cells in culture. (A) Mor
+FGF alone, +FGF/+Nodal (1 or 5 μg/mL); top row, low magniﬁcation, bottom row, hig
examined by Northern blot analysis of TS cells grown in the presence of FGF plus combination
or Nodal (1 or 5 μg/mL) as indicated.However, while TGF-β ligands and receptors are expressed in the
uterine tissue as well as in the developing embryonic and
extraembryonic tissues, mouse mutants have not revealed an
essential role for this pathway in the trophoblast cell lineage
(Goumans and Mummery, 2000; Jones et al., 2006; Kitisin et al.,
2007). Conversely, mouse mutants for the type I Activin receptor
(Acvr1b) result in early embryonic lethality and display a disorga-
nized epiblast and extraembryonic ectoderm at embryonic day (E)
6.5 (Gu et al., 1998). Activin mutants have been made and have no
obvious placental phenotypes (Lau et al., 2000; Matzuk et al., 1995;
Vassalli et al., 1994). However Activin is encoded by three separate
subunit genes, and although single and double mutant mice have
been reported, triple mutants have not. Nodal mutants display a
phenotype similar to Acvr1bmutants, while a hypomorphic mutation
in Nodal results in placental defects affecting trophoblast cells of the
labyrinth, spongiotrophoblast and TGC layers (Ma et al., 2001). More
recently, Nodal has been shown to be important in vivo in
coordination with FGF4 for the maintenance of the TS cellphology of TS cells grown in culture medium+FGF/+EFCM or+FGF/+Activin versus
h magniﬁcation. Scale bar=100 μm. (B) Expression of Esrrb, Gcm1, and Prl3d1 were
s of embryonic ﬁbroblast feeder cell-conditionedmedium (EFCM), Activin (10 ng/mL),
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Nodal is required to maintain FGF4 expression in the epiblast, it has
been unclear if the effect of Nodal on trophoblast development in
vivo is direct or indirect. In addition, because Nodal and Activin signal
through the same receptor complex and downstream Smad proteins,
it has also been unclear if Activin itself has any role. Our current data
suggest that Activin rather than Nodal acts in conjunction with FGF4
directly on TS cells inﬂuencing both TS cell maintenance as well as
trophoblast cell fate.
Materials and methods
Animals
CD-1 male and female mice (Charles River) were crossed to
generate embryos and conceptuses for experiments. Blastocyst stage
embryos for trophoblast stem (TS) cell derivations were ﬂushed
from uteri at embryonic (E) day 3.5 (noon on the day of the vaginal
plug is designated E0.5) while conceptuses for RNA extraction and
histology were dissected from uteri from E7.5 to E15.5 as previously
described (Hogan, 1994; Natale et al., 2006). All animals had free
access to food and water and were housed under normal light
conditions (12 hours light/12 hours dark). All of the animal
procedures were carried out in accordance with the University of
Calgary Animal Care Committee.
Cell culture
Cell culture experiments were carried out with two different
trophoblast stem (TS) cell lines, one derived from a mouse carrying a
LacZ transgene (tgRs26; kindly provided by Janet Rossant) and a new
line derived from blastocyst stage embryos from CD-1 matings as
previously described (Tanaka et al., 1998). TS cells were cultured at
37 °C under 5% CO2 in air and maintained in RPMI 1640 culture
medium (Invitrogen) supplemented with 20% fetal bovine serum
(CanSera), 1 mM sodium pyruvate (Invitrogen), 50 μg/mL penicillin/
streptomycin, 5.5×10−5 M β-mercaptoethanol (Invitrogen), 25 ng/
mL basic ﬁbroblast growth factor (bFGF; Sigma), and 1 μg/mL heparin
(Fisher Scientiﬁc) with 70% of the medium being preconditioned by
incubation with embryonic ﬁbroblasts for 48 hours (Tanaka et al.,
1998). For differentiation conditions, TS cell medium was used as
described above but without supplementation with bFGF, heparin,
and embryonic ﬁbroblast pre-conditioning. TGC-conditioned medium
was generated by incubation with differentiated TGCs for 48 hours
prior to use in experiments. Recombinant human TGF-β1, recombi-
nant human Activin A, recombinant mouse Follistatin and recombi-
nant mouse Nodal (R&D Systems) were used at concentrations of
5 ng/mL, 10 ng/mL, 1 μg/mL, and 1–5 μg/mL, respectively. In
inhibition experiments employing small molecule inhibitors,
SB431542 (Sigma) and TGFβR1 kinase inhibitor (Calbiochem) were
dissolved in DMSO and used at 20 μM. DMSO alone at similar
concentrations was used as a control in these experiments.
RNA isolation, Northern blot, and RT–PCR
Total RNA was collected from ectoplacental cone plus chorion at
E7.5 and E8.5 and from placentas at E11.5 and E15.5 by homogeni-
zation in TRIzol Reagent (Invitrogen), following the manufacturer's
protocol. Total RNA from proliferating or differentiated TS cell cultures
was collected by lysis in RLT buffer and Qiashredder column (Qiagen)
and processing on RNeasy columns (Qiagen) as outlined in the
manufacturer's instructions.
For Northern blot analysis, 10 μg of total RNA was separated by
electrophoresis in 1.1% agarose formaldehyde gels, blotted onto
GeneScreen nylon membrane (Perkin Elmer) and UV cross-linked.
Random-primed DNA labeling of cDNA probes was carried out with25 μCi 32P-dCTP and isolated on Sephadex G-50 columns (Amersham
Biosciences). Hybridizations were at 60 °C overnight as previously
described (Church and Gilbert, 1984).
In RT–PCR, for each sample analysed, 1 μg of total RNA was reverse
transcribed using 750 ng oligo(dT) primers and 200 U of M-MLV
RNaseH-deﬁcient reverse transcriptase (Promega). PCRs were carried
out in the presence of 1.5 mM MgCl2 for 30–35 cycles under the
following conditions: denaturation at 94 °C for 30 s, annealing at 60 °C
for 30 s, and extension at 72 °C for 30 s, followed by a ﬁnal extension of
5minutes at 72 °C. Primer sequences were as follows: Inhba-F, 5′-GGA
GGG CTG GAA GAG GAA AAG GAA, Inhba-R, 5′-TGT TGA GTG GAA GGA
GAG CGA GGA C; Inhbb-F, 5′-GGG TGT TGG GGG AGG GAG AGA A,
Inhbb-R, 5′-GCC CAC TGC CTC CCC TGT CTC T; Inhbc-F, 5′-CTT CGT
AGA CTT CCG TGA GAT TGG CT, Inhbc-R, 5′-CCG AGA TGT AGG CAC
GCA GCA C; Nodal-F, 5′-GAA AAG CAG GTG TCC AGT CGA GCA, Nodal-
R, 5′-CCA GGA GCC CCA GCC AAT CA; Acvr1b-F, 5′-TCA TGA TGC GGT
CAC TGA CAC C, Acvr1b-R, 5′-TCT TTC CCA TCA CTC GCA AGG C;
Acvr2b-F, 5′-CAT CAC GTG GAA CGA ACT GTG C, Acvr2b-R, 5′-AGC ATG
TAC TCA TCG ACA GGC C; Actb-F, 5′-GTG GGC CGC TCT AGG CAC CAA,
Actb-R, 5′-CTC TTT GAT GTC ACG CAC GAT TTC; Gapd-F, 5′-CCA GGA
GCG AGA CCC CAC TAA CA, Gapd-R, 5′-TCG GCA GAA GGG GCG GAG.
Western blot and antibodies
Total cell lysates from TS cell cultures were isolated in RIPA buffer
and analyzed by SDS-PAGE and immunoblotting using standard
procedures. Antibodies recognizing mouse Smad2/3 and the phos-
phorylated form of mouse Smad2 (Cell Signaling Technology) were
used at dilutions suggested by the manufacturer. A horseradish
peroxidase-linked donkey anti-rabbit secondary antibody (GE Health-
care) was used in coordination with ECL plus substrate (GE
Healthcare) to detect the primary antibody.
Tissue preparation and in situ hybridization
Conceptuses for in situ hybridization were dissected at E8.5, ﬁxed
overnight in 4% paraformaldehyde (PFA) in PBS at 4 °C, embedded in
OCT, and sectioned (9 μm) as previously described (Natale et al., 2006;
Simmons et al., 2007, 2008). Digoxigenin-labeled riboprobes were
prepared according to the manufacturer's protocol (Roche). Plasmids
for the preparation of Inha, Inhba, Inhbb, Acvr1b, and Acvr2b
riboprobes were obtained from Dr. Martin Matzuk (Houston, TX,
USA). For the preparation of Cripto and Nodal riboprobes, plasmids
were obtained from Dr. Michael Shen (New York, NY, USA) and Dr.
Brigid Hogan (Durham, NC, USA), respectively. Riboprobes for Gcm1,
Prl2c2, Prl3d1, and Tpbpa have been previously described (Simmons
et al., 2008). Riboprobes for Cryptic (Cfc1), Jarid1c, Ctsb, Sdc1, and
Mmp9 were generated from plasmids following PCR ampliﬁcation,
cloning into pGEM T-easy (Promega) and conﬁrmation of cDNA by
sequencing for each gene. For in situ hybridization, sections were ﬁrst
rehydrated in PBS, then post-ﬁxed in 4% PFA, treated with proteinase
K (15 μg/ml for 5 minutes at room temperature), acetylated for
10 minutes (acetic anhydride, 0.25%; Sigma), and hybridized with
DIG-labeled probes overnight at 65 °C. Hybridization buffer contained
1× salts (200 mM NaCl, 13 mM Tris, 5 mM sodium phosphate
monobasic, 5 mM sodium phosphate dibasic, 5 mM EDTA), 50%
formamide, 10% (wt./vol.) dextran sulfate, 1 mg/ml yeast tRNA
(Sigma), 1× Denhardt's [1% (wt./vol.) bovine serum albumin, 1% (wt./
vol.) Ficoll, 1% (wt./vol.) polyvinylpyrolidine) and cRNA probe (ﬁnal
dilution of 1:2000 from reaction with 1 μg template DNA). Post-
hybridization washes were followed by an RNase treatment [400 mM
NaCl, 10 mM Tris (pH 7.5), 5 mM EDTA, 20 μg/ml RNase A]. After
blocking, sections were incubated overnight at 4 °C in alkaline
phosphatase-conjugated, anti-DIG antibody (Sigma) diluted 1:2500 in
blocking solution. Sections were washed and signals were detected
using alkaline phosphatase immunohistochemistry as previously
Fig. 2. Nodal is bioactive and results in increased phosphorylation of Smad-2 in P19 but not in TS cells. (A) P19 cells were treated with (+) and without (−) Nodal or Activin for 0,
0.25, 1, 4, or 24 hours. Expression of phosphorylated Smad2 (P-Smad2) versus total Smad2/3 was investigated by Western blot analysis. (B) TS cells in culture were treated with
Activin or Nodal for 0, 0.25, 1, or 4 hours in the presence or absence of the Activin type I receptor inhibitor, SB431542. Expression of phosphorylated Smad2 (P-Smad2) versus total
Smad2/3 was investigated by Western blot analysis.
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with nuclear fast red.
Microarray analysis
Microarray experiments were conducted in triplicate on indepen-
dent experiments to examine the inﬂuence of Activin and TGF-β on
differentiating TS cells. RNA was isolated from TS cells differentiated
for 3 days under normal differentiation conditions (minus FGF/
EFCM), in the presence of Activin (10 ng/mL) or in the presence of
TGF-β (5 ng/mL). Gene expression proﬁling was preformed using
Affymetrix MOE-430A chips (Affymetrix, Santa Clara, CA) andFig. 3. The Nodal co-receptor, Cripto, is not expressed in the developing placenta or in
TS cell cultures. (A) mRNA in situ hybridization was performed on E8.5 cryosections of
embryo and placenta to detect expression of Cripto mRNA. Cripto was undetectable in
trophoblast cells of the placenta but was expressed in the heart as previously described.
(B) Cripto mRNA was undetectable by Northern blot in TS cells at 0, 2, 4, or 6 days of
differentiation under normal differentiation conditions (−FGF/EFCM) or in the
presence of Nodal (−FGF/+Nodal) or Activin (−FGF/+Activin). However, Cripto
mRNA was detectable in the P19 embryonal carcinoma cell line. Conversely, Cryptic
mRNA was detectable in TS cells primarily at 4 and 6 days of differentiation but
undetectable in P19 cells. EPC, ectoplacental cone; ch, chorion; nf, neural fold; hrt,
heart. Scale bar=100 μm.conducted by the StemCore Microarray Facility at the Ottawa Health
Research Institute (Ottawa, Canada). Brieﬂy, cDNA target preparation,
labeling, and hybridization were carried out according to standardFig. 4. Messenger RNAs encoding Activin ligand subunits are expressed in TS cells in
culture and in trophoblast cells of the mid-gestation placenta. (A) RT–PCR analysis of
Inhba, Inhbb, Inhbc, and Nodal mRNA at different times throughout gestation in the
placenta. (B) RT–PCR analysis of proliferating (+FGF/EFCM) and differentiating
(−FGF/EFCM) TS cells in culture. (C) In situ hybridization of Inhba and Inhbb mRNA
at E8.5. Inhba and Inhbb mRNA were detected in the EPC and TGCs while Nodal was
detected in the EPC and chorion. Expression of Inha was undetectable in the placenta
while expression of Prl2c2 and Tpbpa indicate parietal TGCs and trophoblast cells of the
EPC, respectively. Dec, decidua; EPC, ectoplacental cone; Ch, chorion.
Fig. 5. Messenger RNAs encoding Activin type 1 and 2 receptors are expressed in trophoblast cells of the mid-gestation placenta and in trophoblast stem cells in culture. (A, B)
Expression of Acvr1b and Acvr2bwere detected by RT–PCR and Northern blot analysis in proliferating (+FGF/EFCM) and differentiating (−FGF/EFCM) TS cells in culture. (C) Acvr1b
and Acvr2b were also detected by RT-PCR throughout gestation in the placenta as well as observed broadly expressed in trophoblast cells of the chorion and EPC at E8.5 by in situ
hybridization (D). Ch, chorion.
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450, and Scanner 3000 (Affymetrix, Santa Clara, CA). Image proces-
sing, normalization, and data analysis were performed using the
Affymetrix Microarray suite 5.0 software. Genes with a false discovery
rate P value of b0.05 and a signal log ratio fold change of greater or less
than 1.5 were considered signiﬁcantly different.
Results
Nodal does not maintain proliferation of trophoblast stem cells in culture
In order to investigate if Nodal has a direct effect on TS cells, similar
to that reported for Activin and TGF-β, we cultured TS cell lines in
medium containing FGF4 alone (+FGF), FGF4 plus embryonic feeder
cell-conditioned medium (+FGF/+EFCM), FGF4 plus Activin or FGF4
plus Nodal (1 and 5 μg/mL). TS cells cultured in either FGF4 plus
EFCM, or FGF4 plus Activin continued to proliferate, formed colonies
with tight epithelial morphology and could be serially passaged every
5 days for several weeks (Fig. 1A). When examined by Northern blot
after 10 days in culture, both of these groups of cells expressed the
trophoblast stem cell marker gene, Esrrb, whereas expression of
Gcm1, a marker of differentiating syncytiotrophoblast, was expressed
at very low levels or was undetectable (Fig. 1B). In contrast, cells
cultured in FGF4 alone or FGF4 plus 1 or 5 μg/mL of Nodal began to
differentiate immediately and showed changes in morphology,
including increases in cell and nuclear size and appearance of TGC-
like cells (Fig. 1A). In addition, the cells failed to proliferate and could
not be maintained past the second passage. Their expression of Essrb
was dramatically reduced and expression of Gcm1 was induced,
indicating trophoblast differentiation (Fig. 1B). In order to ensure that
the Nodal was bioactive, we tested the effect in P19 mouse embryonal
carcinoma cells which respond to Nodal (Kumar et al., 2001). P19 cells
cultured in the presence of Activin or Nodal both showed increased
levels of phosphorylated Smad2 compared to untreated controls
(Fig. 2A). When a similar experiment was conducted in TS cell
cultures, a robust increase in phosphorylated Smad2 was observed in
response to Activin but not to Nodal (Fig. 2B). This response could be
blocked when cells were treated with SB431542 (Fig. 2B), a smallmolecule inhibitor of TGF-β/Activin/Nodal type 1 receptors (Laping
et al., 2002; Ogawa et al., 2007; Watabe et al., 2003).
The Nodal co-receptor Cripto is not expressed in trophoblast stem cells
In order to address why TS cells were non-responsive to Nodal, we
examined the expression of Cripto, a co-receptor required for Nodal,
but not Activin, signaling (Gritsman et al., 1999; Kumar et al., 2001;
Yeo and Whitman, 2001). In cryosections of whole E8.5 mouse
implantation sites examined by RNA in situ hybridization, Cripto
mRNA expression was undetectable in the placenta (Fig. 3A) but was
observed in the heart as previously described (Dono et al., 1993). In
addition, while Cripto mRNA was strongly expressed in P19 cells, it
was virtually undetectable in TS cells by Northern blot analysis
(Fig. 3B). Interestingly, analysis of the closely relatedmolecule Cryptic
(Shen et al., 1997) revealed that, while no expression was detected in
the placenta at E8.5 by in situ hybridization (data not shown) nor in TS
cells in the presence of FGF, Cryptic was strongly induced upon
differentiation of TS cells (Fig. 3B).
Activin ligand and receptor mRNAs are expressed in placenta and TS cell
cultures
To investigate the potential importance of Activin in supporting
trophoblast proliferation both in vitro and in vivo, we characterized
the expression of Activin ligand and receptor mRNAs in the
developing placenta and TS cell cultures. Activin constitutes a dimer
of combinations of three different subunits: βA, βB, and βC, encoded
by the Inhba, Inhbb, and Inhbc genes, respectively (Shi and Massague,
2003). These βA, βB, and βC subunits can also form heterodimers with
an α-subunit, encoded by Inha, to form the hormone Inhibin. Using
RT–PCR we detected expression of β subunits in trophoblast tissues
and the developing placenta beginning at E7.5 as well as in TS cells
both in the presence and absence of FGF4/EFCM (Figs. 4A and B).
When examined by in situ hybridization, Inhba and Inhbb were
localized to cells of the ectoplacental cone and parietal TGCs
surrounding the implantation site as suggested by co-localization
with Tpbpa and Proliferin (Prl2c2), respectively (Fig. 4C). By contrast,
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observed at the base of the ectoplacental cone as well as the chorion
from E8.5 onwards, but was absent from the trophoblast compart-
ment at earlier stages (Fig. 4).
Activin and Nodal (but not TGF-β) signaling are transduced
through a receptor complex made up of Activin receptor type 1
(Acvr1b/ALK4) and Activin receptor type 2 (Acvr2b) subunits (Shi
and Massague, 2003). In TS cell cultures, mRNAs for both Acvr1b and
Acvr2b were detectable by RT–PCR (Fig. 5A). When examined by
Northern blotting, Acvr1b mRNA expression increased in differenti-
ating TS cells while Acvr2b mRNA expression remained relatively
constant (Fig. 5A). In vivo, Acvr1b and Acvr2bmRNAs were detectable
by RT–PCR at E7.5 through E15.5 and were observed by in situ
hybridization to be broadly expressed in all trophoblast cell subtypes
at E8.5 (Fig. 5B).
Activin produced by parietal trophoblast giant cells suppresses TS cell
differentiation
Given that Activin ligand and receptor subunits were expressed in
trophoblast tissues of the developing placenta in vivo and in TS cell
cultures, we tested if Activin produced by parietal TGCs could affect
the differentiation of TS cells. We ﬁrst examined the effect of blocking
all TGF-β/Activin/Nodal signaling by using SB431542 to inhibit TGF-
β/Activin/Nodal type I receptor activity. TS cells cultured in the
presence of FGF4 but in the absence of EFCM (to reduce feeder cell-
derived TGF-β/Activin) were exposed to 20 μM SB431542, as well as
1 μg/mL Follistatin or 20 μM TGFbR1 kinase inhibitor to speciﬁcally
block Activin or TGF-β, respectively. We found that SB431542
promoted differentiation, even in the presence of exogenous Activin,
as expression of trophoblast stem cell marker genes (Eomes and Essrb)
was decreased while markers of TGCs (Prl3d1 and Prl3b1) were
increased in comparison to controls (Fig. 6A). Changes in cell
morphology were also observed as a result of SB431542 treatment
as cells in this group were fewer in number and showed an increase in
frequency of TGCs compared to control (Fig. 6B). In contrast,
treatment with either Follistatin or TGFbR1 kinase inhibitor alone
resulted in minimal decreases in Eomes and Essrb expression and
moderate changes in morphology (Figs. 6A and B). These data suggest
that Activin and TGF-β were both present in the cultures and had
paracrine effects on TS cell differentiation. To investigate this further,
TS cells were cultured in the absence of FGF4 but in the presence of
TGC-conditionedmedium (TGC-CM). Compared to TS cells cultured in
the absence of FGF4 and EFCM, TGC-CM caused a reduction in
expression of differentiated markers Prl3b1 and Prl2c2 (Fig. 6C).
When Follistatin was includedwith TGC-CM, the effect was decreased,
although not completely (Fig. 6C).
Activin promotes differentiation of labyrinth trophoblast subtypes in the
absence of FGF4
Our results indicated that together with FGF4, Activin (and/or
TGF-β) is necessary and sufﬁcient to maintain undifferentiated TS
cells in culture. To further investigate its role in controlling
trophoblast cell differentiation, we tested the effect of Activin after
withdrawal of FGF4, which alone normally results in differentiation
towards both TGC and syncytiotrophoblast fates (Hughes et al., 2004;
Tanaka et al., 1998). In general, TGF-β treatment had only minor
effects on the expression of marker genes; a moderate increase in the
expression of Esrrb as well as in the syncytiotrophoblast cell gene
Syncytin B (Synb) was observed. In addition, the ectoplacental cone
(EPC)/spongiotrophoblast gene, Tpbpa, and the TGC genes, Prl3d1,
Prl3b1, and Prl2c2 (Fig. 7A) exhibited an earlier onset and increased
level of expression (Fig. 7A). In contrast, TS cells differentiated in the
presence of Activin displayed gene expression patterns quite different
from both control and TGF-β-treated groups. Speciﬁcally, Esrrb wasdetectable until day 5 and the onset ofMash2was delayed until day 3
of differentiation. Most signiﬁcantly, expression of the syncytiotro-
phoblast gene Gcm1 began at day 2 and was detectable until day 8 of
differentiation (Fig. 7A). This prolongation of Gcm1 expression was
also accompanied by an increase in Synb expression as well as a
signiﬁcant decrease and/or delay in the expression of Tpbpa, Prl3d1,
Prl3b1, and Prl2c2 (Fig. 7A).
The difference in the effects of Activin and TGF-β was assessed in
more detail by using Affymetrix microarray analysis of RNA collected
from TS cells differentiated in the presence of Activin or TGF-β for
3 days. When compared to controls, several genes were found to be
up- or down-regulated by either Activin or TGF-β. Importantly,
however, the overlap of genes exhibiting altered expression in
response to Activin and TGF-β was relatively minimal with only
1157 genes commonly de-regulated by both Activin and TGF-β. By
contrast, 2098 genes were differentially expressed only in response to
Activin and 681 were changed speciﬁcally to TGF-β (Fig. 7B,
Supplemental Tables). These data indicate that TS cells respond
differentially to Activin and TGF-β.
To further address the requirement for Activin and TGF-β during
TS cell differentiation, we again used the small molecule inhibitor,
SB431542, to block Activin and TGF-β signaling during this process. In
TS cells differentiated in the presence of SB431542, we were unable to
detect expression of Gcm1 (Fig. 7C). In addition, expression of Tpbpa
and Prl3b1 were both delayed and reduced compared to controls
(Fig. 7C). These data suggest that Activin and/or TGF-β signaling is
necessary for TS cell differentiation.
Activin and TGF-β-regulated genes have different patterns of expression
in the developing placenta
To conﬁrm and characterize the expression of genes identiﬁed in
the microarray experiments, we performed further analysis on a
subset of genes that were strongly de-regulated by either Activin or
TGF-β. A total of 15 genes were investigated and conﬁrmed to be
expressed in TS cells by Northern blotting (data not shown).
Expression of these genes was then examined by in situ hybridization
on implantation sites at E8.5 and compared to that of Gcm1 and
Prl3d1, genes which were observed to be differentially expressed in
response to Activin and TGF-β, respectively (Fig. 7A). Of the 15 genes
examined, 11 were undetectable by in situ hybridization while the
remaining 4 were expressed in distinct regions of the developing
trophoblast tissues. Gcm1 and Jarid1c were observed to be up-
regulated by Activin in TS cells. Gcm1 was expressed as previously
described (Anson-Cartwright et al., 2000; Basyuk et al., 1999;
Simmons et al., 2008) in trophoblast cells associated with sites of
initiation of chorio-allantoic branching while Jarid1cwas expressed in
subsets of trophoblast throughout the chorion but was undetectable
in trophoblast cells of the ectoplacental cone (Fig. 8A). Conversely,
while both Ctsb and Sdc1, which were down-regulated by Activin in
TS cells, were expressed in the chorion, their expression was also
detectable in the ectoplacental cone (Fig. 8B). Expressions of Mmp9
and Prl3d1, which were up-regulated in TS cells by TGF-β, were both
restricted to parietal trophoblast giant cells at the interface between
the developing placenta and the maternal decidua and were not
detected in trophoblast cells of the ectoplacental cone or the chorion
(Fig. 8C).
Discussion
The aim of the current study was to investigate the role of TGF-β/
Activin/Nodal signaling in maintaining the pluripotency and control-
ling the differentiation of mouse TS cells. Our results indicate that
proliferating, multipotent TS cells are not responsive to the mature
form of Nodal and that Nodal is not capable of maintaining
undifferentiated TS cells in culture. Activin on the other hand is
Fig. 6. Activin produced by parietal TGCs suppresses TS cell differentiation in culture. (A) Expression of trophoblast stem cell (Eomes, Esrrb) and TGC (Prl3d1, Prl3b1) marker genes in
cultured TS cells. (B) Morphology of cells at low and higher magniﬁcation (scale bar=100 μm). Cells were grown in the presence of FGF or FGF/Activin, with or without (Control)
inhibitors of all type I receptors for TGF-β/Activin/Nodal (SB431542), Activin (Follistatin), or TGF-β (TGF-βR1 inhibitor). Treatment with SB431542 resulted in a reduction of Eomes
and Esrrb, an increase in Prl3d1 and Prl3b1, and an increase in the presence of TGCs. Inhibition of Activin or TGF-β alone also resulted in a slight reduction of Eomes and, in the case of
Follistatin treatment, an increase in Prl3b1. These changes in gene expression were accompanied by moderate changes in morphology, suggesting differentiation, of TS cells cultured
in Follistatin or TGF-βR1 inhibitor. (C) Expression of TGC markers (Prl3b1 and Prl2c2) examined by Northern blot analysis in TS cell cultures. Cells were differentiated as usual
(−FGF/EFCM), or in the presence of TGC-conditioned medium (GC-CM) or TGC-conditioned medium plus Follistatin (GC-CM+Fst). Expression of Prl3b1 and Prl2c2were markedly
reduced in response to GC-CM, an effect that was reversed by the addition of Follistatin.
126 D.R.C. Natale et al. / Developmental Biology 335 (2009) 120–131expressed by trophoblast cells both in culture and in vivo and affects
TS cell maintenance when FGF4 is present and TS cell fate upon
differentiation after FGF4 withdrawal. Based on our results, we
propose the hypothesis that Activin, through paracrine signaling from
TGCs, acts to regulate TS cell differentiation and promotes the
expression of genes required for the formation of the labyrinth layer.
TGF-β/Activin/Nodal signaling is one branch of the greater TGF-β
superfamily of growth factors and has been extensively studied in
early embryonic development (Kitisin et al., 2007; Shi and Massague,
2003). Acting through similar receptor complexes and sharing
downstream effector molecules (Smad2/3 and Smad 4), unique
roles for TGF-β and Activin/Nodal signaling have been elucidated by
gene knockout studies in mice (Goumans andMummery, 2000). With
respect to early embryonic development and placenta formation, TGF-
β signaling has been shown to be indispensable aroundmid-gestation
for extraembryonic endothelial cell differentiation and yolk sacvasculogenesis (Dickson et al., 1995; Larsson et al., 2001; Oshima
et al., 1996). By contrast, Nodal signaling is required for development
of embryonic mesoderm (Iannaccone et al., 1992), primitive streak
(Conlon et al., 1994), and placenta (Guzman-Ayala et al., 2004;
Iannaccone et al., 1992), and similar phenotypes are observed for
mouse embryos with targeted mutations in type I or type II Activin
receptors (Gu et al., 1998; Song et al., 1999). Further studies have
established that Nodal is essential for maintaining the pluripotency of
TS cells in early post-implantation stage embryos working in concert
with FGF4 (Guzman-Ayala et al., 2004). Both FGF4 and Nodal are
expressed by the embryonic ectoderm. The FGF receptor, Fgfr2, is
expressed in trophoblast cells (extraembryonic ectoderm) adjacent to
the FGF signal and is essential for maintaining pluripotency (Guzman-
Ayala et al., 2004).
The mechanism of Nodal action has been less clear. When TS cell
lines were ﬁrst isolated, feeder cells in the form of embryonic
127D.R.C. Natale et al. / Developmental Biology 335 (2009) 120–131ﬁbroblasts (or conditionedmedium from embryonic ﬁbroblasts) were
required to establish and maintain the cells together with FGF4. We
(this study) and others (Erlebacher et al., 2004) have found that
Activin (which works through the same receptors as Nodal) and TGF-
β can replace feeder cells and maintain the proliferation and
pluripotency of cultured TS cells in conjunction with FGF4. Based on
these data, it has been assumed that Nodal acts directly on trophoblast
cells in vivo. However, Nodal is also known to have autocrine effects
on the embryonic ectoderm (Guzman-Ayala et al., 2004), and
therefore, the effects of Nodal in vivo could be indirect through
maintenance of FGF4 production. We addressed this question by
culturing TS cells in Nodal to determine if it was sufﬁcient to maintain
the self-renewing state of TS cells and hence if it could replace the
feeder cell requirement. To our surprise, while we could maintain TSFig. 7. Activin promotes differentiation of labyrinth trophoblast subtypes in the absence o
differentiating trophoblast subtypes in cultures treated with Activin or TGF-β versus contro
signiﬁcantly up- or down-regulated (1.5-fold) versus control in TS cells that were differen
SB431542 during differentiation resulted in a reduction and/or delay of expression of Gcm1cell lines in the presence of FGF4 plus Activin, FGF4 plus Nodal was
without effect even at very high doses. In pursuing this further, we
examined the expression of the closely related molecules Cripto and
Cryptic, co-receptors that are essential for Nodal but not Activin
binding to their common receptor complex (Acvr2b/Acvr1b). We
found that TS cells, both in vitro and in vivo, do not express either
Cripto or Cryptic, although Cryptic expression was detected in
trophoblast differentiated from TS cells in vitro. Taken together,
these data pointed towards a critical role of Activin as opposed to
Nodal in trophoblast stem cell maintenance.
The difference in response to Nodal and Activin implies that spatial
differences in their pattern of expression and activity may be
important. An alternative is that trophoblast cells may respond only
to the preprocessed, uncleaved form of Nodal. The. Nodal precursor,f FGF4 in culture. (A) Northern blot analysis for markers of proliferating TS cells and
ls. (B) Summary of Affymetrix microarray experiments showing the number of genes
tiated for 3 days in the presence of Activin or TGF-β. (C) Treatment of TS cells with
, Tpbpa, and Prl3d1.
Fig. 8. Activin and TGF-β-regulated genes have different expression patterns in vitro and in vivo. The expression of genes identiﬁed as up-regulated (A; Gcm1, Jarid1c) or down-
regulated (B; Ctsb, Sdc1) by Activin or up-regulated by TGF-β (C; Mmp9) were investigated by in situ hybridization on sections of placenta tissue at E8.5. Gcm1 and Jarid1c were
restricted to the chorion while Ctsb and Sdc1were expressed in the top of the chorion as well as the ectoplacental cone.Mmp9 expression overlapped with expression of Prl3d1 and
was restricted to parietal TGCs (arrow). Boxed regions are shown in higher magniﬁcation to the right of each micrograph. Scale bars=100 μm. EPC, ectoplacental cone; Ch, chorion;
Al, allantois.
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Fig. 9. Amodel for paracrine signaling, in which Activin produced by TGCs, controls fate
decisions of TS cells. In the presence of FGF4 (produced by the embryonic ectoderm)
and Activin (produced by TGCs), TS cells proliferate and self-renew. This process is
maintained, as previously described, by Nodal produced by the embryonic ectoderm
that is cleaved and activated by serine proteases (PACE4/Furin) produced by the
extraembryonic ectoderm/TS cell compartment. Activated Nodal, in turn, maintains the
production of FGF4 by the embryonic ectoderm. As TS cells differentiate, paracrine
Activin signaling inhibits the differentiation of spongiotrophoblast and TGCs while
promoting the differentiation of syncytiotrophoblast.
129D.R.C. Natale et al. / Developmental Biology 335 (2009) 120–131which is produced by the epiblast, acts on the extraembryonic
ectoderm to maintain expression of the subtilisin-like proprotein
convertases (SPC) Furin and PACE4 (Ben-Haim et al., 2006). In turn,
Furin and PACE4 cleave the Nodal proprotein into its mature, active
form thereby providing a source of active Nodal that acts on the
epiblast to maintain FGF4 expression and to specify anterior visceral
endoderm and mesoderm in the embryo (Ben-Haim et al., 2006;
Guzman-Ayala et al., 2004). Taken together, TS cells appear to be able
to respond only to the unprocessed form of Nodal; however, this does
not exclude the possibility that differentiated trophoblast may, in fact,
respond to processed Nodal.
While previous studies also implied that Activin and TGF-β have
similar effects on TS cells (Erlebacher et al., 2004), our cumulative
data indicate that these two factors have different effects and roles in
regulating trophoblast development. Both Activin and TGF-β, when
combined with FGF4, are capable of maintaining undifferentiated TS
cell proliferation in vitro (Erlebacher et al., 2004). However, they have
very different effects on differentiating TS cells after withdrawal from
FGF4 as shown by both microarray analysis of global gene expression
and expression studies of speciﬁc differentiation markers. The spatial
expression patterns of TGF-β ligands (Slager et al., 1991; Tamada
et al., 1990) and receptors have been documented (Mariano et al.,
1998; Roelen et al., 1994). While TGF-β ligands and receptors are
broadly expressed in the maternal decidua, and developing embryo,
the primary sites of receptor expression (and therefore signaling
activity) in the placenta at mid-gestation are in the EPC and TGC layer
(Mariano et al., 1998; Roelen et al., 1994). Based on the response of TS
cells in vitro to TGF-β (this study and (Erlebacher et al., 2004), we
expect that cells in the chorionwould also be responsive to this ligand.
However, while Acvr1b mutants (therefore deﬁcient in Activin/Nodal
signaling) have trophoblast defects, none of the targeted mutants in
TGF-β ligands or receptors show a trophoblast phenotype (Goumans
and Mummery, 2000; Jones et al., 2006). This suggests that TGF-β
signaling is not likely to be important for maintaining the TS cell
environment in vivo.
In contrast to TGF-β, our data support a role for Activin in vivo such
that it mediates a paracrine signaling interaction between TGCs and
TS cells. Using in situ hybridization and RT–PCR, we could not detect
expression of Inha (encoding theα subunit) mRNA, but detected all of
the β subunits (Inhba, Inhbb, and Inhbc). The strongest expression was
in parietal TGCs, which surround the implantation site and are the
ﬁrst differentiated type of trophoblast cells to form during develop-
ment (Muntener and Hsu, 1977). In support of the idea that Activin is
produced in vivo and feeds back to TS cells, TGC-conditioned medium
had an activity that could maintain the expression of stem cell
markers and suppress the expression of differentiated markers that
was at least partially reversible by Follistatin (a binding protein
inhibitor of Activin but not TGF-β or Nodal) (Shi andMassague, 2003).
TGF-β is present in the serum of cultured cells, and this may have
limited the reversibility of the effect. This is supported by the fact that
inhibition of both TGF-β and Activinwith SB431542was very effective
in promoting TS cell differentiation, whereas inhibition of TGF-β
signaling on its own had little or no effect.
Activin receptor expression was detectable throughout the
trophoblast lineage at E8.5, not just in the chorion where trophoblast
progenitor cells reside. These data implied that Activin could act on
various different cell types including those that are beginning to
differentiate. To determine if this was the case, we removed FGF4
from TS cell cultures but maintained them in the presence of Activin.
Compared to control cells, TGF-β, if anything, promoted TGC
differentiation based on the expression of TGC-speciﬁc genes,
although some transient Synb expression, indicative of syncytiotro-
phoblast, was detected. This is consistent with our ﬁnding thatMmp9,
a gene expressed by parietal TGCs, is up-regulated in response to TGF-
β. By contrast, Activin maintained the expression of Esrrb (stem cell
marker), delayed the onset of Mash2 expression (spongiotrophoblastand chorion), suppressed onset and level of TGC markers (Prl3d1,
Prl3b1, and Prl2c2), and maintained the expression of Gcm1
throughout the time course. In addition, when we examined the in
vivo expression patterns of genes found to be responsive to Activin,
those that were up-regulated (Gcm1 and Jarid1c) were expressed
exclusively in trophoblast cells of the chorion. We have previously
presented a model that trophoblast cells in the chorion contain
progenitors of the labyrinth layer, including syncytiotrophoblast
(Simmons et al., 2008). Those genes that were down-regulated by
activin (Sdc1 and Ctsb) were expressed in the chorion, but also in the
ectoplacental cone, which gives rise to spongiotrophoblast and TGCs
(Simmons et al., 2007, 2008). These data suggest that when TS cells
begin to differentiate upon withdrawal of FGF4, Activin promotes
differentiation away from the TGC fate and toward syncytiotropho-
blast cell fate. Because TGCs produce Activin, it implies that Activin
acts as part of a negative feedback loop to regulate further TGC
differentiation (Fig. 9). This effect is similar to that observed in retinal
development, where retinal ganglion cells (RGCs) and amacrine cells
secrete factors to inhibit the differentiation of additional cells of that
type. In RGCs, the factor is growth and differentiation factor-11
(GDF11) (Kim et al., 2005; Liem et al., 1997), whereas in amacrine
cells, it is TGF-βII (Ma et al., 2007), both of which are members of the
TGF-β superfamily (Shi andMassague, 2003). In addition, however, in
the trophoblast cell lineage, Activin has a permissive and/or
instructional effect in promoting an alternative fate, namely differen-
tiation towards Gcm1-positive syncytiotrophoblast. The increase in
Gcm1 expression was accompanied by an increase in Synb expression,
which we have shown to be co-expressed with Gcm1 in syncytio-
trophoblast (Simmons et al., 2008) and is known to promote cell–cell
fusion (Dupressoir et al., 2005). It is notable that while the effect on
130 D.R.C. Natale et al. / Developmental Biology 335 (2009) 120–131Gcm1 expression was dramatic, we did not see morphological
evidence of extensive trophoblast cell–cell fusion. It may be that
other factors are required to promote that ﬁnal step in differentiation
such as interactions with the allantois (Cross et al., 2006).
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